
/PRNewswire/ — CAPS Medical, a clinical-stage MedTech company developing a platform for selective tumor ablation across multiple indications, today announced…
Read the full article at: www.prnewswire.com

/PRNewswire/ — CAPS Medical, a clinical-stage MedTech company developing a platform for selective tumor ablation across multiple indications, today announced…
Read the full article at: www.prnewswire.com